Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides

ClinicalTrials.gov ID: NCT00001028

Public ClinicalTrials.gov record NCT00001028. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Comparative, Prospective Study of Monthly Aerosolized Pentamidine and Thrice Weekly Dapsone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant to Trimethoprim and/or Sulfonamides

Study identification

NCT ID
NCT00001028
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
400 participants

Conditions and interventions

Interventions

  • Pentamidine isethionate Drug
  • Dapsone Drug

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
May 31, 1994
Last update posted
Oct 31, 2021

Ends 1994

United States locations

U.S. sites
14
U.S. states
12
U.S. cities
13
Facility City State ZIP Site status
Community Consortium of San Francisco San Francisco California 94110
Denver CPCRA / Denver Public Hlth Denver Colorado 802044507
Wilmington Hosp / Med Ctr of Delaware Wilmington Delaware 19899
Veterans Administration Med Ctr / Regional AIDS Program Washington D.C. District of Columbia 20422
AIDS Research Alliance - Chicago Chicago Illinois 60657
Wishard Hosp / Indiana Univ Hosp Indianapolis Indiana 46202
Louisiana Comm AIDS Rsch Prog / Tulane Univ Med New Orleans Louisiana 70112
Comprehensive AIDS Alliance of Detroit Detroit Michigan 48201
Henry Ford Hosp Detroit Michigan 48202
North Jersey Community Research Initiative Newark New Jersey 071032842
Harlem AIDS Treatment Group / Harlem Hosp Ctr New York New York 10037
Bronx Lebanon Hosp Ctr The Bronx New York 10456
Portland Veterans Adm Med Ctr / Rsch & Education Grp Portland Oregon 972109951
Richmond AIDS Consortium Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00001028, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00001028 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →